Introduction: The optimal timing of surgical stabilization of rib fractures (SSRF) remains debated. We hypothesized that 1) demographic, radiologic, and clinical variables are associated with time to surgery and 2), shorter time to SSRF improves acute outcomes. Methods: Prospectively collected SSRF databases from four trauma centers were merged and analyzed (2006-2016). The independent variable was days from hospital admission to SSRF [early ( 24 hours) mechanical ventilation, pneumonia, tracheostomy, length of stay, and mortality. Multivariable logistic regression was used to control for significant differences in covariates between groups. Results: 551 patients were analyzed. The median time to SSRF was 1 day (range 0-10); 207 (37.6%) patients were in the early group, 168 (30.5%) in the mid group, and 186 (31.9%) in the late group. There was a significant shift towards earlier SSRF over the study period. Time to SSRF was significantly associated with study center (p
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2zevUDa
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters P2Y2 Nucleotide ...
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
Abstract Objective We sought to validate an algorithm designed to identify patients with post-gastric bypass hypoglycemia (PGBH) using c...
-
European Journal of Clinical Investigation from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2kayzXi
-
Objectives: To determine the prevalence of compassion fatigue, burnout, and compassion satisfaction and identify potential personal and prof...
-
Abstract Introduction Systemic sclerosis (SSc) is a complex autoimmune disease, characterized by microvascular lesions, autoimmunity, an...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου